NCT00488267View on ClinicalTrials.gov

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

679

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Osteoarthritis
Interventions
DRUG

ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System)

Transdermal patch applied to the knee for 12 hours daily.

DRUG

Placebo Matrix/CHADD Patch

Transdermal patch applied to the knee for 12 hours daily.

DRUG

Ketoprofen matrix/placebo CHADD Patch

Transdermal knee applied to the knee for 12 hours daily.

Trial Locations (36)

16508

Erie

16635

Duncansville

17055

Mechanicsburg

20902

Wheaton

21239

Baltimore

27408

Greensboro

27612

Raleigh

29572

Myrtle Beach

29621

Anderson

33024

Pembroke Pines

33143

South Miami

33458

Jupiter

33614

Tampa

33761

Clearwater

37205

Nashville

47714

Evansville

48910

Lansing

62704

Springfield

64114

Kansas City

66215

Overland Park

77090

Houston

78217

San Antonio

83704

Boise

84106

Salt Lake City

85381

Peoria

90620

Buena Park

91361

Westlake Village

92103

San Diego

92801

Anaheim

97035

Lake Oswego

97239

Portland

98405

Tacoma

99204

Spokane

06518

Hamden

06460

Milford

08619

Mercerville

All Listed Sponsors
lead

ZARS Pharma Inc.

INDUSTRY

NCT00488267 - Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter